TG Therapeutics
TGTX · NASDAQ
Bulios Fair Price
$33.05
42.2% downside
Trenutna cena
$57.16
Po podatkih Bulios Fair Price je delnica TGTX trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
TG Therapeutics, Inc. (TGTX) is a biotechnology company specializing in the development of therapeutic products in the fields of oncology and autoimmune diseases. The company focuses on discovering and developing innovative treatment approaches that could improve the quality of life for patients suffering from these diseases. TG Therapeutics, Inc. (TGTX) shares may be suitable for investors seeking opportunities in the biotechnology sector and keeping an eye on advancements in the treatment of oncological and autoimmune diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Michael S. Weiss
Employees
399
Headquarters
Morrisville
Prihajajoči dogodki
Earnings
Upcoming earnings report